Biotech companies by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 24 biotech companies ranked by short interest, at 19.2%, ahead of CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Scholar Rock Holding19.2%
Median
9.33%
Combined market value
PLN 3.38T
Countries
5

Market values as of .

All countries
All sectors
Biotech
PLN
Clear filters
Biotech companies by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%PLN 23.2BPLN 189.97 4.84% up 14% up United States
2CRISPR TherapeuticsCRSP · Health Care17.7%PLN 16.4BPLN 168.88 4.65% up 21% down Switzerland
3Twist BioscienceTWST · Health Care14.4%PLN 32.3BPLN 473.67 5.21% up 340% up United States
4Kodiak SciencesKOD · Health Care12.4%PLN 25.4BPLN 389.10 0.00% 396% up United States
5Halozyme TherapeuticsHALO · Health Care12.0%PLN 44.2BPLN 387.81 0.53% up 37% up United States
6ImmunityBioIBRX · Health Care11.9%PLN 28.6BPLN 26.91 6.95% up 193% up United States
7RepligenRGEN · Health Care11.0%PLN 44.6BPLN 698.25 7.11% up 5% up United States
8ExelixisEXEL · Health Care10.5%PLN 67.8BPLN 277.84 0.91% up 63% up United States
9CG OncologyCGON · Health Care10.3%PLN 29.4BPLN 328.74 3.60% up 85% up United States
10Krystal BiotechKRYS · Health Care10.3%PLN 37.2BPLN 1,256.27 4.68% up 46% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%PLN 41.9BPLN 490.91 0.50% up 87% up United States
12VaxcytePCVX · Health Care9.70%PLN 37.4BPLN 236.05 1.14% down 22% up United States
13ImmunovantIMVT · Health Care8.96%PLN 27.8BPLN 134.34 0.63% up 43% up United States
14ModernaMRNA · Health Care8.20%PLN 327.5BPLN 809.39 2.63% down 755% up United States
15Adaptive BiotechnologiesADPT · Health Care7.09%PLN 18.7BPLN 115.52 0.88% up 88% up United States
16Revolution MedicinesRVMD · Health Care6.05%PLN 138.4BPLN 639.78 2.17% down 131% up United States
17Neurocrine BiosciencesNBIX · Health Care5.83%PLN 66.6BPLN 657.99 1.34% down 20% up United States
18Bio-TechneTECH · Health Care4.90%PLN 46BPLN 292.65 0.24% up 26% up United States
19BiogenBIIB · Health Care3.69%PLN 149.8BPLN 1,013.17 0.51% up 49% up United States
20QiagenQGEN · Health Care3.10%PLN 41.2BPLN 199.73 0.12% down 12% up Netherlands
21AmgenAMGN · Health Care2.33%PLN 970.5BPLN 1,794.15 2.53% down 34% up United States
22argenxARGX · Health Care2.25%PLN 239.2BPLN 3,803.23 0.14% down 4% up Belgium
23Gilead SciencesGILD · Health Care1.72%PLN 844.4BPLN 680.80 0.52% down 33% up United States
24BioNTechBNTX · Health Care0.91%PLN 83.7BPLN 337.61 1.03% down 16% down Germany

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0196 PLN).

Questions and answers

Which biotech companies rank first by short interest?

Scholar Rock Holding (19.2%), CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%) are the top three of the 24 biotech companies ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech companies are in this ranking?

24 are ranked by short interest.

What are these biotech companies worth together?

The 24 biotech companies ranked by short interest have a combined market value of PLN 3.38T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.